Literature DB >> 21875841

Factors and outcomes of decision making for cancer clinical trial participation.

Barbara A Biedrzycki1.   

Abstract

PURPOSE/
OBJECTIVES: To describe factors and outcomes related to the decision-making process regarding participation in a cancer clinical trial.
DESIGN: Cross-sectional, descriptive.
SETTING: Urban, academic, National Cancer Institute-designated comprehensive cancer center in the mid-Atlantic United States. SAMPLE: 197 patients with advanced gastrointestinal cancer.
METHODS: Mailed survey using one investigator-developed instrument, eight instruments used in published research, and a medical record review. INDEPENDENT VARIABLES: disease context, sociodemographics, hope, quality of life, trust in healthcare system, trust in health professional, preference for research decision control, understanding risks, and information. DEPENDENT VARIABLES: decision to accept or decline research participation and satisfaction with this decision.
FINDINGS: All of the factors within the Research Decision Making Model together predicted cancer clinical trial participation and satisfaction with this decision. The most frequently preferred decision-making style for research participation was shared (collaborative) (83%).
CONCLUSIONS: Multiple factors affect decision making for cancer clinical trial participation and satisfaction with this decision. Shared decision making previously was an unrecognized factor and requires further investigation. IMPLICATIONS FOR NURSING: Enhancing the process of research decision making may facilitate an increase in cancer clinical trial enrollment rates. Oncology nurses have unique opportunities as educators and researchers to support shared decision making by those who prefer this method for deciding whether to accept or decline cancer clinical trial participation.

Entities:  

Mesh:

Year:  2011        PMID: 21875841     DOI: 10.1188/11.ONF.542-552

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  9 in total

1.  Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

Authors:  Lydia T Madsen; Deborah A Kuban; Seungtaek Choi; John W Davis; Jeri Kim; Andrew K Lee; Delora Domain; Larry Levy; Louis L Pisters; Curtis A Pettaway; John F Ward; Christopher Logothetis; Karen E Hoffman
Journal:  J Natl Compr Canc Netw       Date:  2014-07       Impact factor: 11.908

2.  Engaging patients and caregivers in patient-centered outcomes research on advanced stage lung cancer: insights from patients, caregivers, and providers.

Authors:  K M Islam; Samuel T Opoku; Bettye A Apenteng; Ann Fetrick; June Ryan; M Copur; Addison Tolentino; Irfan Vaziri; Apar K Ganti
Journal:  J Cancer Educ       Date:  2014-12       Impact factor: 2.037

3.  Factors affecting patient participation in clinical trials in Ireland: A narrative review.

Authors:  Elaine Walsh; Ann Sheridan
Journal:  Contemp Clin Trials Commun       Date:  2016-03-02

4.  Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study.

Authors:  Pia Dellson; Kerstin Nilsson; Helena Jernström; Christina Carlsson
Journal:  Trials       Date:  2018-09-29       Impact factor: 2.279

5.  The perceived severity of a disease and the impact of the vocabulary used to convey information: using Rasch scaling in a simulated oncological scenario.

Authors:  Roberto Burro; Ugo Savardi; Maria Antonietta Annunziata; Paolo De Paoli; Ivana Bianchi
Journal:  Patient Prefer Adherence       Date:  2018-12-03       Impact factor: 2.711

6.  Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.

Authors:  Norma F Kanarek; Marty S Kanarek; Dare Olatoye; Michael A Carducci
Journal:  Trials       Date:  2012-12-10       Impact factor: 2.279

7.  Patients' rationale for declining participation in a cancer-associated weight loss study.

Authors:  Tammy Wanger; Nathan R Foster; Phuong L Nguyen; Aminah Jatoi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-03-13       Impact factor: 12.910

8.  What influenced people with chronic or refractory breathlessness and advanced disease to take part and remain in a drug trial? A qualitative study.

Authors:  N Lovell; S N Etkind; S Bajwah; M Maddocks; I J Higginson
Journal:  Trials       Date:  2020-02-22       Impact factor: 2.279

9.  "When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.

Authors:  Joseph M Unger; Dawn L Hershman; Cathee Till; Lori M Minasian; Raymond U Osarogiagbon; Mark E Fleury; Riha Vaidya
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.